JLABS - From Chemical to Drug: The Path to a Small Molecule IND


 
09/20/2017 - 11:30am to 1:00pm

JLABS - From Chemical to Drug: The Path to a Small Molecule IND
Wednesday, September 20, 2017, 11:30am - 1:00pm, JLABS, 3210 Merryfield Row, San Diego, CA 92121. Register 

Do you have a solid plan to achieve IND acceptance? Filing an Investigational New Drug (IND) application might be the next step in advancing your company's early-stage drug development program. Johnson & Johnson Innovation, JLABS (JLABS) and Janssen Discovery Sciences invite you to an in-depth look into the process of filing an IND. Whether your goal is to develop a pipeline through commercial launch or partner as early as possible, submitting an IND is a critical early milestone for every biotech company. With big Pharma and VC firms competing for the most promising compounds, startups are expected to demonstrate a clear blueprint for IND approval, and we want you to be ready. 

The presentations will highlight the following: 
 

  • Janssen Research & Development - your partner of choice
  • Preclinical Development Strategies for pharmacokinetics, drug metabolism and toxicology
  • Role of patient behavior in development of solutions
  • Key CMC strategies to balance cost, time and quality risks
  • Designing First-in-Human trials to highlight the qualities of your molecule
  • Regulatory strategy, IND requirements, and Pre-IND meetings
For more information on this event, contact: 
JLABS
Event Calendar: 
Location: 
JLABS, 3210 Merryfield Row, San Diego, CA 92121
sharknado